Holen Sie sich die Stockscreener-App
1.02
2.86%
-0.03
Handel nachbörslich:
1.06
0.04
+3.92%
Finanzdaten der Clearside Biomedical Inc-Aktie (CLSD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
96.38%
0.23
|
6.345 | 0.859 | 1.018 | 0.004 |
Operating Expenses
|
8.87%
8.439
|
9.26 | 7.913 | 8.288 | 7.609 |
| Benefits Costs and Expenses |
7.30%
11.99
|
11.18 | - | - | 9.284 |
| Costs And Expenses |
7.30%
11.99
|
11.18 | 7.913 | 8.288 | 9.284 |
| Operating Income/Loss |
181.61%
-8.209
|
-2.915 | -7.054 | -7.27 | -7.605 |
| Income/Loss From Continuing Operations Before Tax |
143.44%
-11.76
|
-4.832 | 0.859 | -9.106 | -9.28 |
| Income/Loss From Continuing Operations After Tax |
143.44%
-11.76
|
-4.832 | -9.267 | -9.106 | -9.28 |
|
Net Income/Loss
|
143.44%
-11.76
|
-4.832 | -9.267 | -9.106 | -9.28 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
34,599%
69.85
|
0.2013 | 61.98 | 61.65 | 61.17 |
| Diluted Average Shares |
34,599%
69.85
|
0.2013 | 61.98 | 61.65 | 61.17 |
| Basic Earnings Per Share |
112.50%
-0.17
|
-0.08 | -0.15 | -0.15 | -0.15 |
| Diluted Earnings Per Share |
112.50%
-0.17
|
-0.08 | -0.15 | -0.15 | -0.15 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):